Skip to main content

IDEAYA Biosciences, Inc.

IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001676725

In the last 90 days, IDEAYA Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 285 institutions reported holding it in 13F filings for Q2 2026, worth $3.80B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding IDEAYA Biosciences, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025All holders in Q2 2025

13F holders of IDYA: Q2 2025 compared with Q3 2025
MeasureQ2 2025Of which not filed for Q3 2025Q3 2025Change
Holders2044224+24
Shares96.8M54.1K94.1M−2.68M (−2.8%)
Value$2.04B$1.14M$2.56B+$525.8M (+25.9%)

4 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (45)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to IDYA in Q3 2025
InstitutionSharesValue% of portfolio
Tang Capital Management LLC400,000$10.9M0.42%
AXA Investment Managers S.A.325,513$8.86M0.02%
Iron Triangle Partners LP270,000$7.35M1.04%
Franklin Resources Inc235,425$6.41M0.00%
Susquehanna Portfolio Strategies, LLC163,263$4.44M0.07%
Canada Pension Plan Investment Board110,300$3.00M0.00%
Sphera Funds Management Ltd.100,000$2.72M0.65%
MML Investors Services, LLC81,369$2.21M0.01%
Trexquant Investment LP56,275$1.53M0.02%
Dark Forest Capital Management LP53,715$1.46M0.05%
Winton Group Ltd42,283$1.15M0.04%
Tudor Investment Corp Et Al37,595$1.02M0.01%
Knights of Columbus Asset Advisors LLC34,337$934.3K0.05%
Fifth Lane Capital, LP34,237$931.6K0.94%
Weiss Asset Management LP23,321$634.6K0.01%
Oxford Asset Management LLP22,007$598.8K0.20%
Wesbanco Bank Inc21,200$576.9K0.02%
Cetera Investment Advisers20,904$568.8K0.00%
Brevan Howard Capital Management LP20,679$562.7K0.01%
ADAR1 Capital Management, LLC20,000$544.2K0.05%
Graham Capital Management, L.P.14,712$400.3K0.01%
Fox Run Management, L.L.C.12,105$329.4K0.05%
Jain Global LLC11,760$320.0K0.00%
Universal- Beteiligungs- und Servicegesellschaft mbH9,630$262.0K0.00%
Mariner, LLC9,554$260.0K0.00%
Beirne Wealth Consulting Services, LLC8,587$233.7K0.06%
CIBC Bancorp USA Inc.8,561$232.9K0.00%
Park Avenue Securities LLC8,308$226.0K0.00%
Truist Financial Corp8,169$222.3K0.00%
Capstone Investment Advisors, LLC8,050$219.0K0.00%
Point72 Europe (London) LLP3,276$89.1K0.00%
Abich Financial Wealth Management LLC2,120$57.7K0.02%
Quadrant Capital Group LLC1,563$42.5K0.00%
Aster Capital Management (DIFC) Ltd1,386$37.7K0.02%
Simplex Trading, LLC1,122$30.0K0.00%
Antipodes Partners Ltd770$21.0K0.00%
Optiver Holding B.V.528$14.4K0.00%
Groupe la Francaise600$13.9K0.00%
Rockefeller Capital Management L.P.324$8.82K0.00%
SRS Capital Advisors, Inc.290$7.89K0.00%
Cullen/Frost Bankers, Inc.93$2.53K0.00%
Halbert Hargrove Global Advisors, LLC86$2.34K0.00%
Transamerica Financial Advisors, Inc.61$1.66K0.00%
ORG Partners LLC20$5440.00%
JPL Wealth Management, LLC10$2730.00%

Sold out (21)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Not filed for Q3 2025 yet (4)

Institutions that held IDEAYA Biosciences, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IDYA in Q2 2025 that haven't filed for Q3 2025
InstitutionShares, Q2 2025Value, Q2 2025
Norges Bank30,589$643.0K
E Fund Management Co., Ltd.12,225$257.0K
CIBC World Markets Corp10,324$217.0K
First Horizon Advisors, Inc.934$19.6K